LAUREN SHUTT: Open Payments
NPI 1154714624 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 42 payments from 13 companies in 2025. Trend: 2023 $314 · 2024 $649 · 2025 $940
Food & beverage: $852Education: $88
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $200 |
| Novartis Pharmaceuticals Corporation | 8 | $164 |
| Janssen Biotech, Inc. | 8 | $143 |
| GENZYME CORPORATION | 3 | $90 |
| UCB, Inc. | 3 | $66 |
| Amgen Inc. | 3 | $64 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $51 |
| Galderma Laboratories, L.P. | 3 | $46 |
| Lilly USA, LLC | 2 | $35 |
| ABBVIE INC. | 1 | $27 |
Products named: DUPIXENT, TREMFYA, COSENTYX, Bimzelx, OTEZLA, Winlevi, NEMLUVIO, RINVOQ.
Industry payments across VA — which companies pay providers there.
